• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Coinbase Enhances User Experience with Smart Wallet Verification Upgrade

chest

Coinbase has launched a Smart Wallet verification upgrade aimed at simplifying multichain dApp access for users.

user avatarAyman Ben Youssef

Ethereum's Future Depends on Institutional Interest and Market Signals

chest

The future of Ethereum hinges on institutional interest and market signals as traders await proof of sustained demand.

user avatarTando Nkube

Ethereum Market Dynamics Amid ETF Launch Speculation

chest

Ethereum's market is showing signs of caution as traders become more selective ahead of potential ETF launches.

user avatarKofi Adjeman

Market Signals and Bitcoin's Recovery

chest

Bitcoin's recovery is supported by ETF inflows and a calmer derivatives market, but requires confirmation from spot demand.

user avatarNguyen Van Long

Kraken Expands Support for Arbitrum-based Stablecoins

chest

Kraken's recent update to support Arbitrum-based stablecoins marks a significant shift in the exchange's approach to Layer 2 networks, allowing for more efficient transactions and addressing high fees on Mainnet Ethereum.

user avatarSatoshi Nakamura

SEC Moves Towards Formal Crypto Regulation

chest

The SEC is moving towards formal rulemaking for cryptocurrency firms to provide clearer guidelines and reduce uncertainty in the industry.

user avatarJesper Sørensen

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.